Phoenix, AZNCT06866405Now EnrollingIRB Ready

RSV Clinical Trial in Phoenix, AZ

Access cutting-edge rsv treatment through this phase 3 clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.

Sponsored by Pfizer

Quick Self-Assessment

See if you qualify for this Phoenix location

Preparing your pre-screening questions…

Expert Care in Phoenix

Access rsv specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related rsv treatment provided free

Apply for This Phoenix Location

Check if you qualify for this rsv clinical trial in Phoenix, AZ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Phoenix

    Convenient for AZ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Phoenix site if eligible
  4. 4Begin participation

About This RSV Study in Phoenix

This study aims to check how safe and well-tolerated a second dose of RSVpreF is when given during later pregnancies, and to see how long the immunity lasts from a single dose given during a previous pregnancy by examining the blood of nonpregnant participants who had the vaccine before.

Sponsor: Pfizer

Who Can Participate

Inclusion Criteria

Women aged 18 to 49 who are pregnant, between 24 and 36 weeks along, and expecting one baby without known risks for complications can participate.
Had the RSVpreF or Abrysvo vaccine during a previous pregnancy.
Had an ultrasound scan at 18 weeks or later during their current pregnancy, with no major fetal problems detected.
Based on their medical history, physical check-up, and the doctor's judgment, they are found suitable to join the study.
Agrees to let their baby take part in the study and gives their permission.
Able to sign a consent form, agreeing to follow the rules and conditions of the study. Key

Exclusion Criteria

Received any approved or experimental RSV vaccine since their previous pregnancy.
Has a pre-pregnancy body mass index (BMI) over 40 kg/m2.
History of a severe bad reaction to a vaccine or a serious allergic reaction (like anaphylaxis) to any ingredient in the study vaccine or a similar vaccine.
Current pregnancy problems or issues at the time of giving consent.
Previous pregnancy issues or problems at the time of giving consent.
Women who are breastfeeding at the time of enrollment Infant Participants
Proof that the parent(s) or legal guardian(s) has signed and dated a consent form.
Parent(s) or legal guardian(s) must agree to attend scheduled visits and follow the study plan, including laboratory tests and other procedures. Nonpregnant Participants-Cohort 3 Key Inclusion Criteria
Have already received one dose of the RSVpreF vaccine during their previous pregnancy as part of the Pfizer clinical trial, and the results from that time can be used for this study.
Able to sign a consent form, agreeing to follow the rules and requirements of the study. Key Exclusion Criteria
Received any approved or experimental RSV vaccine after participating in the Pfizer clinical trial.
Taking part in other studies with new drugs within 28 days before giving consent or during the study period.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Phoenix?

Yes, this clinical trial (NCT06866405) has an active research site in Phoenix, AZ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

RSV Treatment Options in Phoenix, AZ

If you're searching for rsv treatment options in Phoenix, AZ, this clinical trial (NCT06866405) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Phoenix research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced rsv specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all rsv clinical trials near you to find additional studies recruiting in your area.

More RSV Trials in Phoenix, AZ

See all rsv clinical trials recruiting in Phoenix — not just this study.

Browse RSV Trials in Phoenix →

Browse More Trials by Condition

RSV TrialsAll Conditions →

Ready to Join in Phoenix?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Phoenix, AZ